Class IIReported 2025-05-07

Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 90 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-452-15

Recalled by ACCORD HEALTHCARE, INC.

Reason for Recall

Subpotent

Recall Number

D-0397-2025

Classification

Class II

Status

Ongoing

Category

drug

Initiated

2025-04-10

Reported

2025-05-07

Distribution

Nationwide US.

Code Info

Lot # D2400725, Exp Date: 03/2026

Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.